RUBICON RESEARCH (RUBICON) Share Price Falls 4.73% Today to Rs 1,729.50

Published:   16 September 2026 at 10:47:30 AM IST

Rubicon Research Share Price fell today after the stock ended at Rs 1,729.50, down 4.73% from the previous close of Rs 1,815.30. The company’s market capitalisation stands at Rs 30,430.56 crore, placing Rubicon Research in the Large Cap category. The move is relevant because Rubicon Research Share Price Today shows a clear same-day decline, but the supplied data does not establish a company-specific catalyst. Rubicon Research Stock News therefore centres on verified price action, valuation context, and healthcare sector comparison. Investors tracking Rubicon Research Share News can see that the move came alongside a fresh intraday range and a wide valuation gap versus several listed peers on Univest.

The stock opened at Rs 1,812.00, touched a high of Rs 1,812.70 and a low of Rs 1,716.40. Turnover stood at Rs 2.35 crore. Rubicon Research Share Price Today also needs to be read with the company’s valuation metrics: P/E of 104.26, P/B of 22.39, ROE of 27.84%, ROCE of 29.22%, EPS of 17.41, book value of Rs 81.09 and dividend yield of 0.08%. This article from Univest explains what changed in price terms and how the reported numbers frame Rubicon Research Share Price News Today.

RUBICON RESEARCH (RUBICON) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,729.5
Previous Close	Rs 1,815.3
Today's Move	-Rs 85.80 (-4.73%)
Open	Rs 1,812
High	Rs 1,812.7
Low	Rs 1,716.4
Turnover	Rs 2.35 crore
Market Capitalisation	Rs 30,430.56 crore
Market Cap Category	Large Cap

Rubicon Research Share Price Today closed at Rs 1,729.50 against the previous close of Rs 1,815.30, marking a fall of Rs 85.80 or 4.73%. The day began at Rs 1,812.00, which was close to the previous close, and the stock then moved within a range of Rs 1,716.40 to Rs 1,812.70. That means the lowest point of the day was Rs 98.90 below the open and Rs 112.10 below the day’s high.

For Rubicon Research Stock News readers, the main point is simple: today’s price action was negative in percentage terms and the close finished well below the opening level. The market capitalisation of Rs 30,430.56 crore confirms the company remains in the Large Cap category, which is important background for Rubicon Research Share Price analysis. On Univest, this kind of move is best read as a verified price event first, with no company-specific reason established by the supplied data. Rubicon Research Share Price Fall therefore reflects today’s observed trade, not a stated trigger. From here, the more useful question becomes how the stock is valued and how it compares with healthcare peers.

RUBICON RESEARCH (RUBICON) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 30,430.56 crore
P/E Ratio	104.26x
P/B Ratio	22.39x
ROE	27.84%
ROCE	29.22%
EPS	Rs 17.41
Book Value Per Share	Rs 81.09
Dividend Yield	0.08%

Rubicon Research Fundamental Analysis shows a company with a large market capitalisation of Rs 30,430.56 crore and a valuation that is materially above the supplied industry reference points. The stock trades at a P/E ratio of 104.26 and a P/B ratio of 22.39. Its ROE of 27.84% and ROCE of 29.22% are both strong on an absolute basis, while EPS stands at Rs 17.41 and book value at Rs 81.09 per share. Dividend yield is 0.08%, which is a factual yield measure at the current price.

Against these figures, Rubicon Research Share Price Today is not being discussed as cheap or expensive in isolation, but the industry benchmark helps frame the numbers. In the same industry universe, the median P/E is 31.74 and the average P/E is 47.98, while the median P/B is 3.02 and the average P/B is 4.44. Rubicon Research Share Price therefore sits above those benchmark levels on both valuation measures. ROE and ROCE are also above the industry median and average of 11.78% and 11.19% for ROE, and 13.65% and 13.65% for ROCE. That combination is central to Rubicon Research Stock Analysis on Univest.

Rubicon Research Share Price News is therefore framed by a company that has strong profitability ratios but also a rich valuation profile versus its sector set. Investors following Rubicon Research Latest News should watch how the numbers evolve in future company updates and results.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	104.26x
Benchmark Median P/E	31.74x
Benchmark Average P/E	47.98x
Benchmark P/E Range	3.29x to 683.37x
Company P/B Ratio	22.39x
Benchmark Median P/B	3.02x
Benchmark Average P/B	4.44x
Company ROE	27.84%
Benchmark Median ROE	11.78%
Benchmark Average ROE	11.19%
Company ROCE	29.22%
Benchmark Median ROCE	13.65%
Benchmark Average ROCE	13.65%
Company Market Capitalisation	Rs 30,430.56 crore
Benchmark Median Market Cap	Rs 750.5 crore
Benchmark Average Market Cap	Rs 14,144.11 crore

Rubicon Research operates in Healthcare within the Pharmaceuticals & Drugs industry. The supplied benchmark scope covers the same industry and includes 200 companies, with P/E data from 169 companies, P/B data from 199 companies, and ROE and ROCE data from 199 companies each. This gives Rubicon Research Share Price Today a useful reference frame rather than a standalone reading. The company’s P/E of 104.26 is well above the industry median of 31.74 and average of 47.98. Its P/B of 22.39 is also above the median of 3.02 and average of 4.44.

On profitability, Rubicon Research’s ROE of 27.84% is above the industry median of 11.78% and average of 11.19%, while ROCE of 29.22% is above the median and average of 13.65%. In market-cap terms, the industry median is Rs 750.50 crore and the average is Rs 14,144.11 crore, while Rubicon Research Market Cap is Rs 30,430.56 crore. That places Rubicon Research Share Price in a much larger company group than the median industry name. The sector performance and industry benchmark therefore show a company with stronger profitability ratios than the reference set, but also a valuation that is higher than the benchmark central tendency. For Univest readers, Rubicon Research Stock Performance is best seen through that combination of size, valuation and sector placement.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries	SUNPHARMA	4,41,957.5	36.4	5.09	14.85	19.11
Divi's Laboratories	DIVISLAB	2,47,576	83.41	13.81	16.19	21.51
Torrent Pharmaceuticals	TORNTPHARM	1,89,233.01	84.58	20.55	26.76	19.27
Zydus Lifesciences	ZYDUSLIFE	1,11,670.55	24.29	4.07	19.69	21.39
Cipla	CIPLA	1,10,272.68	32.62	3.13	11.83	16

Rubicon Research Share Price also stands out when compared with listed peers in the same healthcare and pharmaceuticals & drugs set. Among the supplied peer group, Sun Pharmaceutical Industries has a market cap of Rs 4,41,957.50 crore, P/E of 36.4 and P/B of 5.09. Divi’s Laboratories has a P/E of 83.41 and P/B of 13.81, while Torrent Pharmaceuticals shows a P/E of 84.58 and P/B of 20.55. Zydus Lifesciences has a P/E of 24.29 and P/B of 4.07, and Cipla has a P/E of 32.62 and P/B of 3.13.

Against those names, Rubicon Research Share Price carries a higher P/E of 104.26 and a higher P/B of 22.39 than every peer listed here. Its ROE of 27.84% is also higher than Sun Pharma, Divi’s, Zydus and Cipla, and slightly above Torrent’s 26.76%. ROCE of 29.22% is above all the supplied peers as well. On market capitalisation, Rubicon Research is larger than Zydus, Cipla, Dr. Reddy’s, Aurobindo Pharma, Lupin, Mankind and the other peers shown in the broader benchmark set, though below Sun Pharma and the larger listed names. That makes Rubicon Research Share Price a notable data point in Rubicon Research Stock News today.

Why Investors Are Watching Rubicon Research

• Rubicon Research Share Price fell 4.73% today to Rs 1,729.50, versus the previous close of Rs 1,815.30.
• The stock moved between Rs 1,716.40 and Rs 1,812.70 after opening at Rs 1,812.00.
• Rubicon Research Market Cap stands at Rs 30,430.56 crore and the company is in the Large Cap category.
• Rubicon Research Fundamental Analysis shows P/E of 104.26, P/B of 22.39, ROE of 27.84% and ROCE of 29.22%.
• Rubicon Research Share Price is above the industry benchmark on P/E and P/B, while also showing stronger ROE and ROCE than the benchmark median.

About Rubicon Research

Rubicon Research operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data places the company in that classification and shows it alongside other listed Indian pharmaceutical names on Univest. Rubicon Research Share Price Today is therefore being viewed within a healthcare and drug-manufacturing context, with valuation and profitability ratios available for comparison. The company’s market capitalisation, EPS, book value and dividend yield add further financial context to Rubicon Research Share News and Rubicon Research Stock Analysis.

For readers following Rubicon Research Company News, the most relevant facts remain the company’s category, valuation, and relative placement within its sector peer set. Univest tracks those details so Rubicon Research Share Price can be reviewed alongside sector benchmarks and other listed companies.

Track Rubicon Research Share Price on Univest

Use RUBICON RESEARCH (RUBICON) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.

Track Rubicon Research Share Price on Univest for live price updates, valuation ratios, shareholding pattern, market capitalisation, 52-week levels and market insights. The Univest stock page also helps readers review Rubicon Research Share Price Today with the company’s peer context and sector benchmark in one place.

Frequently Asked Questions

Why did Rubicon Research share price fall today?

Ans.  Rubicon Research Share Price fell 4.73% to Rs 1,729.50 from Rs 1,815.30. The supplied data confirms the price event, but it does not establish a company-specific catalyst for the decline.

What is Rubicon Research Share Price Today?

Ans.  Rubicon Research Share Price Today is Rs 1,729.50. The stock opened at Rs 1,812.00, hit a high of Rs 1,812.70 and a low of Rs 1,716.40 during the session. The previous close was Rs 1,815.3.

What is Rubicon Research market capitalisation?

Ans.  Rubicon Research Market Cap is Rs 30,430.56 crore. The company is classified as Large Cap in the supplied data, which is useful background for Rubicon Research Share Price analysis. The company operates in the Healthcare sector.

How does Rubicon Research compare with sector benchmarks?

Ans.  Rubicon Research Share Price carries a P/E of 104.26 and P/B of 22.39, both above the industry median and average. Its ROE and ROCE are also above the benchmark central tendency.

How does Rubicon Research compare with peers on valuation?

Ans.  Rubicon Research Share Price has a higher P/E and P/B than the supplied peers such as Sun Pharma, Divi’s Laboratories, Torrent Pharma, Zydus Lifesciences and Cipla. Its ROE and ROCE are also among the stronger figures listed.